Galectin Therapeutics Inc (GALT)
3.23
+0.09
(+2.87%)
USD |
NASDAQ |
May 17, 16:00
3.235
0.00 (0.00%)
After-Hours: 20:00
Galectin Therapeutics Shares Outstanding: 62.15M for May 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 08, 2024 | 62.15M |
March 31, 2024 | 62.15M |
February 29, 2024 | 61.90M |
December 31, 2023 | 61.85M |
November 08, 2023 | 61.85M |
October 10, 2023 | 61.85M |
September 30, 2023 | 61.85M |
September 01, 2023 | 59.58M |
August 08, 2023 | 59.58M |
June 30, 2023 | 59.58M |
May 08, 2023 | 59.58M |
March 31, 2023 | 59.58M |
March 15, 2023 | 59.46M |
February 28, 2023 | 59.44M |
December 31, 2022 | 59.43M |
November 10, 2022 | 59.43M |
October 10, 2022 | 59.43M |
September 30, 2022 | 59.43M |
September 01, 2022 | 59.40M |
August 10, 2022 | 59.40M |
June 30, 2022 | 59.40M |
May 09, 2022 | 59.39M |
March 31, 2022 | 59.39M |
February 28, 2022 | 59.36M |
December 31, 2021 | 59.34M |
Date | Value |
---|---|
November 05, 2021 | 59.34M |
October 07, 2021 | 59.29M |
September 30, 2021 | 59.34M |
September 01, 2021 | 59.29M |
August 10, 2021 | 59.28M |
June 30, 2021 | 59.28M |
May 10, 2021 | 58.09M |
March 31, 2021 | 57.19M |
February 28, 2021 | 57.16M |
December 31, 2020 | 57.08M |
November 05, 2020 | 57.08M |
October 13, 2020 | 57.08M |
October 01, 2020 | 57.08M |
September 30, 2020 | 56.89M |
August 06, 2020 | 57.04M |
June 30, 2020 | 57.04M |
May 05, 2020 | 57.03M |
March 31, 2020 | 57.03M |
February 21, 2020 | 57.03M |
December 31, 2019 | 56.89M |
November 06, 2019 | 56.89M |
October 10, 2019 | 56.78M |
September 30, 2019 | 56.66M |
August 09, 2019 | 56.63M |
August 06, 2019 | 56.63M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
55.99M
Minimum
May 28 2019
62.15M
Maximum
Mar 31 2024
58.76M
Average
59.34M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Madrigal Pharmaceuticals Inc | 21.31M |
Viking Therapeutics Inc | 110.27M |
89bio Inc | 98.38M |
Terns Pharmaceuticals Inc | 64.68M |
Enanta Pharmaceuticals Inc | 21.18M |